ACM
ABBV icon

Aurdan Capital Management’s AbbVie ABBV Stock Holding History

Aurdan Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Buy
+876
New +$188K 0.06% 95
2026
Q1 		– Sell
-876
Closed -$200K – 89
2025
Q4 		$200K Hold
876
– – 0.06% 86
2025
Q3 		$203K Buy
+876
New +$178K 0.06% 90

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Aurdan Capital Management's ABBV Position: Q2 2026 in Review

Aurdan Capital Management opened a new position in AbbVie (ABBV) in Q2 2026: 876 shares worth $220K. The stake represents 0.06% of the portfolio and ranks #95 among its holdings. This is a return to the name: Aurdan Capital Management previously reported a position in ABBV as recently as Q4 2025.

Aurdan Capital Management first reported a position in ABBV in Q3 2025 and has held it in 3 quarters since. 2,127 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Aurdan Capital Management held 876 shares of AbbVie worth $220K as of Q2 2026.
  • AbbVie was a new Aurdan Capital Management position in Q2 2026.
  • AbbVie made up 0.06% of Aurdan Capital Management's portfolio in Q2 2026, its #95 holding.
  • Aurdan Capital Management first reported a position in AbbVie in Q3 2025 and has held it in 3 quarters since.
  • 2,127 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Aurdan Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.